Whitney F. Maxwell

Whitney F. Maxwell, CGC, MS

Languages spoken: English

Academic Information

Departments Adjunct - Population Health Sciences , Adjunct - Huntsman Cancer Institute , Adjunct - Internal Medicine

Divisions: Oncology

Whitney Maxwell is a board-certified genetic counselor with a master’s degree in human genetics and genetic counseling from Emory University and a bachelors and master's degree from Brigham Young University in psychology. She is the Director of Huntsman's Inherited Cancer Research Shared Resource and is a clinical genetic counselor in the Family Cancer Assessment Clinic. She specializes in assessing genetic risk factors for breast and ovarian cancer including BRCA1/2, ATM, CHEK2, PALB2. She also works on multiple research projects aimed at expanding genetic risk assessment into new populations.

Selected Publications

Journal Article

  1. Kaphingst KA, Kohlmann W, Chambers RL, Goodman MS, Bradshaw R, Chan PA, Chavez-Yenter D, Colonna SV, Espinel WF, Everett JN, Gammon A, Goldberg ER, Gonzalez J, Hagerty KJ, Hess R, Kehoe K, Kessler C, Kimball KE, Loomis S, Martinez TR, Monahan R, Schiffman JD, Temares D, Tobik K, Wetter DW, Mann DM, Kawamoto K, Del Fiol G, Buys SS, Ginsburg O, BRIDGE research team. (2021). Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial. BMC Health Serv Res, 21(1), 542. (Read full article)
  2. Sutherland N, Espinel W, Grotzke M, Colonna (2020). Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults. Journal of genetic counseling, 29(4), 625-633. (Read full article)
  3. Espinel W, Charen K, Huddleston L, Visootsak J, Sherman (2016). Improving Health Education for Women Who Carry an FMR1 Premutation. Journal of genetic counseling, 25(2), 228-38. (Read full article)
  4. Allen EG, Grus WE, Narayan S, Espinel W, Sherman S (2014). Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study. Frontiers in genetics, 5, 260. (Read full article)
  5. Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney (2019). Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing. Cancer medicine, 8(15), 6789-6798. (Read full article)

News & Podcasts

Huntsman Cancer Institute News